testosterone 1.62% gel

DRUG2 trials

Sponsors

University of Washington, Seattle Institute for Biomedical and Clinical Research

Conditions

Androgen DeficiencyCancerFatigueHypogonadism, MaleInsulin ResistanceMetabolic DiseaseObesityType 2 Diabetes Mellitus

Phase 1

T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin

CompletedNCT01686828

University of WashingtonAndrogen Deficiency, Insulin Resistance, Metabolic Disease +2

Start: 2013-06-30End: 2017-12-31Updated: 2018-05-08

Phase 2

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Active, not recruitingNCT04301765

Seattle Institute for Biomedical and Clinical ResearchCancer, Fatigue, Hypogonadism, Male

Start: 2021-01-12End: 2026-11-01Target: 230Updated: 2026-07-06

Related Papers

Testosterone replacement therapy for fatigue, sexual dysfunction, and quality of life in older men with cancer (TEMEC).

Journal of Clinical Oncology2025-05-28